Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Search Icon
Search Icon
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Maternal & Public HealthAbortion Drugs Health Services Research & Managerial Epidemiology

A Post Hoc Exploratory Analysis: Induced Abortion Complications Mistaken for Miscarriage in the Emergency Room are a Risk Factor for Hospitalization

Read about how the publisher censored this paper by retracting it and how the authors sued to fight back: See the Assault on Science website and the Arbitration Demand.

Additional Author: Christopher Craver

Abstract

Introduction

Previous research indicates that an increasing number of women who go to an emergency room for complications following an induced abortion are treated for a miscarriage, meaning their abortion is miscoded or concealed.

Objective

To determine if the failure to identify a prior induced abortion during an ER visit is a risk factor for higher rates of subsequent hospitalization.

Methods

Post hoc analysis of hospital admissions following an induced abortion and ER visit within 30 days: 4273 following surgical abortion and 408 following chemical abortion; abortion not miscoded versus miscoded or concealed at prior ER visit.

Results

Chemical abortion patients whose abortions are misclassified as miscarriages during an ER visit subsequently experience on average 3.2 hospital admissions within 30 days. 86% of the patients ultimately have surgical removal of retained products of conception (RPOC). Chemical abortions are more likely than surgical abortions (OR 1.80, CL 1.38-2.35) to result in an RPOC admission, and chemical abortions concealed are more likely to result (OR 2.18, CL 1.65-2.88) in a subsequent RPOC admission than abortions without miscoding. Surgical abortions miscoded/concealed are similarly twice as likely to result in hospital admission than those without miscoding.

Conclusion

Patient concealment and/or physician failure to identify a prior abortion during an ER visit is a significant risk factor for a subsequent hospital admission. Patients and ER personnel should be made aware of this risk.

 

Read Assaultonscience.org

Read Press Release

Read Complete Article

Latest Posts

August 7, 2026 A hand in a blue glove holds a box labeled Mifepristone Tablets with a barcode and description stating its use for pregnancy termination and medical abortion, while recent controversies have brought increased attention to both Mifepristone and its uses beyond abortion. Uses for Mifepristone Beyond Abortion: Addressing Recent Controversies July 20, 2026 A woman in a hospital gown is in labor, holding someone's hand for support while medical staff assist during childbirth, closely monitoring for any medical indications that might require separating mother and unborn child. Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child July 20, 2026 Abortion Reporting: Wyoming (2025)

You Might Also Be Interested In

A hand in a blue glove holds a box labeled Mifepristone Tablets with a barcode and description stating its use for pregnancy termination and medical abortion, while recent controversies have brought increased attention to both Mifepristone and its uses beyond abortion.

Uses for Mifepristone Beyond Abortion: Addressing Recent Controversies

August 7, 2026
Please login to bookmark Close
A woman in a hospital gown is in labor, holding someone's hand for support while medical staff assist during childbirth, closely monitoring for any medical indications that might require separating mother and unborn child.

Fact Sheet: Medical Indications for Separating a Mother and Her Unborn Child

July 20, 2026
Please login to bookmark Close

Abortion Reporting: Wyoming (2025)

July 20, 2026
Please login to bookmark Close

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image